4:01 PM ET
8-K
Leadership Change
BridgeBio Oncology Therapeutics Leadership Change
Yong Ben, M.D., M.B.A. has resigned as the Chief Medical and Development Officer of BridgeBio Oncology Therapeutics, Inc., effective January 8, 2027. The company stated the resignation was not due to any disagreement regarding operations, policies, or practices.